Mónica Hernández Alava

PhD

School of Medicine and Population Health

Professor in Health Econometrics

Mónica Hernández Alava
Profile picture of Mónica Hernández Alava
monica.hernandez@sheffield.ac.uk
+44 114 222 0736

Full contact details

Mónica Hernández Alava
School of Medicine and Population Health
Regent Court (ScHARR)
30 Regent Street
Sheffield
S1 4DA
Profile

I joined ScHARR from the Department of Economics in August 2009. Previously I was a lecturer in the Department of Economics at the University of Birmingham. I obtained a PhD, MSc in Economics and BSc in Business Economics from the University of Leicester. I am also a research associate at the , University of Essex.

Research interests

My main research interests lie in microeconometrics, the analysis of micro level data on the economic behaviour of individuals. I am also interested in more general model and methods development to analyse individual level data showing nonstandard characteristics. Recent examples include analysis of health state utility data, the economics of illicit behaviour, the dynamics of children developmental outcomes and applications to individuals’ decisions to participate in welfare programmes.

Current projects

Understanding Society’s Biomarker Data Project Fellowship

Publications

Show: Featured publications All publications

Journal articles

  • Falk Hvidberg M & Hernández Alava M (2023) . PharmacoEconomics, 41(10), 1287-1388.
  • Hernández Alava M, Pudney SE & Wailoo AJ (2023) . Value in Health, 26(9), 1398-1404.
  • Hernandez-Alava M & Pudney S (2022) . Health Economics, 31(6), 923-939.
  • Wailoo A, Alava MH, Pudney S, Barton G, O’Dwyer J, Gomes M, Irvine L, Meads D & Sadique Z (2021) . Value in Health, 24(4), 568-574.
  • Hernandez M, Wailoo A, Pudney S, Gray L & Manca A (2020) . Health Technology Assessment, 24(34).
  • Hernandez M & pudney S (2018) EQ5DMAP: a command for mapping between EQ-5D-3L and EQ-5D-5L. The Stata journal, 18(2), 395-415.
  • Gray LA, Hernandez Alava M & Wailoo AJ (2018) . Value in Health, 21(6), 748-757.
  • Hernandez Alava M, Wailoo A, Grimm S, Pudney S, Gomes M, Sadique Z, Meads D, O’Dwyer J, Barton G & Irvine L (2018) . Value in Health, 21(1), 49-56.
  • Gibson LA, Hernandez M, Kelly M & Campbell M (2017) . Journal of Public Health, 39(4), e152-e160.
  • Hernandez-Alava M & Pudney S (2017) . Journal of Health Economics, 55, 139-152.
  • Hernandez- Alava M & Popli G (2017) . Demography, 54(2), 485-511.
  • Wailoo AJ, Hernandez M, Manca A, Mejia A, Ray J, Crawford B, Botteman M & Busschbach J (2017) . Value in Health, 20(1), 18-27.
  • Hernandez Alava M & Wailoo A (2015) Fitting adjusted limited dependent variable mixture models to EQ-5D. Stata Journal, 15(3), 737-750.
  • Hernández Alava M, Wailoo A, Wolfe F & Michaud K (2014) . Med Decis Making, 34(7), 919-930.
  • Hernández Alava M, Wailoo A, Wolfe F & Michaud K (2013) . Rheumatology (Oxford), 52(5), 944-950.
  • Alava MH, Brazier J, Rowen D & Tsuchiya A (2013) . Med Decis Making, 33(6), 839-852.
  • Hernández Alava M, Wailoo AJ & Ara R (2012) . Value Health, 15(3), 550-561.

Book chapters

  • Hernandez M (2019) , Oxford Research Encyclopedia of Economics and Finance Oxford University Press

All publications

Journal articles

  • Sasso A, Schelleman-Offermans K, Hernández Alava M, Holmes J, Meier PS & Field M (2025) . Addiction Research and Theory.
  • Worboys HM, Gray L, Burton J, Alava MH, Greenwood S & Cooper N (2025) . Value in Health, 28(7), 1091-1099.
  • Pennington B, Hernández Alava M & Strong M (2025) . PharmacoEconomics, 43(4), 389-402.
  • Meier PS, Holmes J, Stevely A, Boyd JE, Alava MH, Hardie I, Warde A & Sasso A (2025) . Drug and Alcohol Review, 44(1), 144-156.
  • Pennington BM, Alava MH & Strong M (2025) . Value in Health, 28(1), 138-147.
  • Wilson LB, Bain M, Hernandez-Alava M, Holmes J, Pryce R, Sasso A, Stevely AK, Warde A & Meier PS (2025) . Journal of Studies on Alcohol and Drugs, 86(1), 39-47.
  • Pennington B, Hernandez M & Strong M (2024) HOW DOES UNPAID CAREGIVING AFFECT HEALTH-RELATED QUALITY OF LIFE? LONGITUDINAL ANALYSIS OF SF-6D FOR CARERS IN THE UK. VALUE IN HEALTH, 27(12).
  • Pennington B & Hernandez M (2024) . Value in Health, 27(12), S3-S3.
  • Maslyankov I & Hernández M (2024) . PLOS ONE, 19(10).
  • Squires H, Kelly MP, Gilbert N, Sniehotta F, Purshouse RC, Garcia L, Breeze P, Brennan A, Gardner B, Bright S , Fischer A et al (2024) . BMC Public Health, 24(1).
  • Holmes J, Sasso A, Hernández Alava M, Borges Neves R, Stevely AK, Warde A & Meier PS (2024) . International Journal of Drug Policy, 127.
  • Hnynn Si PE, Hernández-Alava M, Dunn L, Wilkie M & Fotheringham J (2023) . BMC Nephrology, 24(1).
  • Holmes J, Sasso A, Hernández Alava M, Stevely AK, Warde A, Angus C & Meier PS (2023) . SSM - Population Health, 24.
  • Hernandez Alava M, Sasso A, Hnynn Si PE, Gittus M, Powell R, Dunn L, Thokala P & Fotheringham J (2023) . Acta Dermato-Venereologica, 103.
  • Falk Hvidberg M & Hernández Alava M (2023) . PharmacoEconomics, 41(10), 1287-1388.
  • Franklin M & Hernández Alava M (2023) . Quality of Life Research, 32(10), 2763-2778.
  • Si PEH, Hernandez M, Sasso A, Gittus M, Powell R, Dunn L & Fotheringham J (2023) . Nephrology Dialysis Transplantation, 38(Supplement_1).
  • Stevely AK, Mackay D, Alava MH, Brennan A, Meier PS, Sasso A & Holmes J (2023) . Public Health, 220, 43-49.
  • Hernández Alava M, Pudney SE & Wailoo AJ (2023) . Value in Health, 26(9), 1398-1404.
  • Breeze PR, Squires H, Ennis K, Meier P, Hayes K, Lomax N, Shiell A, Kee F, de Vocht F, O’Flaherty M , Gilbert N et al (2023) . Health Economics, 32(7), 1603-1625.
  • Hvidberg M, Petersen K, Davidsen M, Witt Udsen F, Frølich A, Ehlers L & Hernandez M (2023) . MDM Policy & Practice, 8(1).
  • Bowen JM, Hernandez M, Johnson DS, Green C, Kammin T, Baker D, Keigwin S, Makino S, Taylor N, Watson O , Wheeldon NM et al (2023) . European Journal of Human Genetics.
  • Warde A, Sasso A, Holmes J, Hernandez Alava M, Stevely A & Meier P (2023) . Nordic Studies on Alcohol and Drugs, 40(3), 301-318.
  • Thokala P, Hnynn Si PE, Hernandez Alava M, Sasso A, Schaufler T, Soro M & Fotheringham J (2023) . PharmacoEconomics, 41, 457-466.
  • Tappenden P, Navega Biz A, Hernández Alava M, Sasso A, Sutton L, Ennis K, Elliott R & Wildman M (2023) . International Journal of Technology Assessment in Health Care, 39(1).
  • Hernández Alava M, Pudney S & Wailoo A (2023) . PharmacoEconomics, 41(2), 199-207.
  • Gray LA, Hernandez Alava M & Wailoo AJ (2022) . BMC Cancer, 22(1).
  • Holmes J, Sasso A, Alava MH, Neves RB, Stevely AK, Warde A & Meier PS (2022) . Lancet, 400 Suppl 1, S50.
  • Sasso A, Hernández-Alava M, Holmes J, Field M, Angus C & Meier P (2022) . Social Science & Medicine, 310.
  • Hernandez-Alava M & Pudney S (2022) . Health Economics, 31(6), 923-939.
  • Hernandez Alava M, Wailoo A, Chrysanthou G, Barcelos F, van Gaalen F, Santos H, Fagerli K, Gago L, Margarida Cunha M, van de Sande M , Couto M et al (2022) . RMD Open, 8(1).
  • Poku E, Harnan S, Rooney G, James MM-S, Hernandez M, Schaufler T, Thokala P & Fotheringham J (2022) . Clinical Kidney Journal, 15(3), 484-499.
  • Opazo Breton M, Gillespie D, Pryce R, Bogdanovica I, Angus C, Hernandez Alava M, Brennan A & Britton J (2022) . Addiction, 117(5), 1392-1403.
  • Gray L, Hernandez Alava M & Wailoo A (2021) . BMC Cancer, 21(1).
  • Wildman MJ, O’Cathain A, Hind D, Maguire C, Arden MA, Hutchings M, Bradley J, Walters SJ, Whelan P, Ainsworth J , Tappenden P et al (2021) . Programme Grants for Applied Research, 9(11), 1-146.
  • Wailoo A, Alava MH, Pudney S, Barton G, O’Dwyer J, Gomes M, Irvine L, Meads D & Sadique Z (2021) . Value in Health, 24(4), 568-574.
  • Pennington BM, Hernández-Alava M, Hykin P, Sivaprasad S, Flight L, Alshreef A & Brazier J (2020) . Value in Health, 23(7), 928-935.
  • Hernandez M, Wailoo A, Pudney S, Gray L & Manca A (2020) . Health Technology Assessment, 24(34).
  • Hernandez Alava M, Pudney S & Wailoo A (2020) . Value in Health, 23(5), 642-648.
  • Kiadaliri A, Alava MH, Roos EM & Englund M (2019) . Quality of Life Research.
  • Pennington B, Hernandez-Alava M, Pudney S & Wailoo A (2019) . PharmacoEconomics, 37(1), 75-84.
  • Gray LA, Wailoo A & Hernandez M (2018) . Value in Health, 21(12), 1399-1405.
  • Hernandez M & pudney S (2018) EQ5DMAP: a command for mapping between EQ-5D-3L and EQ-5D-5L. The Stata journal, 18(2), 395-415.
  • Gray LA, Hernandez Alava M & Wailoo AJ (2018) . Value in Health, 21(6), 748-757.
  • Gray LA, Hernandez M, Kelly M & Campbell M (2018) . BMC Public Health, 18.
  • Gray LA & Alava MH (2018) A command for fitting mixture regression models for bounded dependent variables using the beta distribution. Stata Journal, 18, 51-75.
  • Hernandez Alava M, Wailoo A, Grimm S, Pudney S, Gomes M, Sadique Z, Meads D, O’Dwyer J, Barton G & Irvine L (2018) . Value in Health, 21(1), 49-56.
  • Gibson LA, Hernandez M, Kelly M & Campbell M (2017) . Journal of Public Health, 39(4), e152-e160.
  • Hernandez-Alava M & Pudney S (2017) . Journal of Health Economics, 55, 139-152.
  • Hernandez- Alava M & Popli G (2017) . Demography, 54(2), 485-511.
  • Mukuria C, Rowen D, Hernández-Alava M, Dixon S & Ara R (2017) . Applied Health Economics and Health Policy, 15(5), 597-614.
  • Wailoo AJ, Hernandez M, Manca A, Mejia A, Ray J, Crawford B, Botteman M & Busschbach J (2017) . Value in Health, 20(1), 18-27.
  • Ward Fuller G, Hernandez M, Pallot D, Lecky F, Stevenson M & Gabbe B (2017) . Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 20(1), 141-151.
  • Stevenson M, Archer R, Tosh J, Simpson E, Everson-Hock E, Stevens J, Hernandez-Alava M, Paisley S, Dickinson K, Scott D , Young A et al (2016) . Health Technology Assessment, 20(35), 611-614.
  • Rowen D, Dixon S, Hernández-Alava M & Mukuria C (2016) . European Journal of Health Economics , 17(6), 733-744.
  • Stevenson M, Archer R, Tosh J, Simpson E, Everson-Hock E, Stevens J, Hernandez-Alava M, Paisley S, Dickinson K, Scott D , Young A et al (2016) . Health Technology Assessment, 20(35), 1-610.
  • Hernandez M & Pudney S (2016) bicop: A command for fitting bivariate ordinal regressions with residual dependence characterized by a copula function and normal mixture marginals. The Stata Journal, 16(1), 159-184.
  • Hernandez Alava M & Wailoo A (2015) Fitting adjusted limited dependent variable mixture models to EQ-5D. Stata Journal, 15(3), 737-750.
  • Wailoo A, Hernández M, Philips C, Brophy S & Siebert S (2015) . Value in Health, 18(4), 425-431.
  • Wailoo A, Hernandez Alava M, Scott IC, Ibrahim F & Scott D (2014) . Rheumatology, 53(10), 1773-1777.
  • Hernández Alava M, Wailoo A, Wolfe F & Michaud K (2014) . Med Decis Making, 34(7), 919-930.
  • Wailoo A, Hernandez Alava M & Escobar Martinez A (2014) . Health Qual Life Outcomes, 12, 37.
  • Stevenson M, Gomersall T, Lloyd Jones M, Rawdin A, Hernández M, Dias S, Wilson D & Rees A (2014) . Health Technol Assess, 18(17), 1-290.
  • Longworth L, Yang Y, Young T, Mulhern B, Hernández Alava M, Mukuria C, Rowen D, Tosh J, Tsuchiya A, Evans P , Devianee Keetharuth A et al (2014) . Health Technol Assess, 18(9), 1-224.
  • Wailoo AJ, Hernandez M & Escobar Martinez A (2013) . VALUE IN HEALTH, 16(7), A606-A606.
  • Kearns B, Ara R, Wailoo A, Manca A, Alava MH, Abrams K & Campbell M (2013) . Pharmacoeconomics, 31(8), 643-652.
  • Hernández Alava M, Wailoo A, Wolfe F & Michaud K (2013) . Rheumatology (Oxford), 52(5), 944-950.
  • Alava MH, Brazier J, Rowen D & Tsuchiya A (2013) . Med Decis Making, 33(6), 839-852.
  • Hernández Alava M, Wailoo AJ & Ara R (2012) . Value Health, 15(3), 550-561.
  • Ara R, Blake L, Gray L, Hernández M, Crowther M, Dunkley A, Warren F, Jackson R, Rees A, Stevenson M , Abrams K et al (2012) . Health Technol Assess, 16(5), iii-195.
  • Rowen D, Brazier J, Tsuchiya A & Alava MH (2012) . Health Economics, 21(6), 715-729.
  • Wailoo AJ, Hernandez M & Ara R (2011) . VALUE IN HEALTH, 14(7), A242-A242.
  • Wailoo A, Goodacre S, Sampson F, Alava MH, Asseburg C, Palmer S, Sculpher M, Abrams K, de Belder M & Gray H (2010) . Heart, 96(9), 668-672.
  • Hernandez M, Pudney S & Hancock R (2007) . J APPL ECONOM, 22(3), 581-598.
  • Hernandez M & Pudney S (2007) . J PUBLIC ECON, 91(1-2), 327-341.
  • Hancock R, Pudney S, Barker G, Hernandez M & Sutherland H (2004) . Fiscal Studies, 25(3), 279-303.
  • Hernández M (2002) . Contributions to Economics, 19-36.
  • Stevenson MD, Wailoo AJ, Tosh JC, Hernandez-Alava M, Gibson L, Stevens JW, Archer R, Simpson EL, Hock ES, Young A & Scott DL () . Journal of Rheumatology, 44(7), 973-980.

Book chapters

  • Hernandez M (2019) , Oxford Research Encyclopedia of Economics and Finance Oxford University Press

Conference proceedings

  • Thokala P, Si PEH, Hernandez M, Sasso A, Schaufler T, Soro M & Fotheringham J (2024) Cost-Effectiveness of Difelikefalin compared to Standard Care for treating Chronic Kidney Disease Associated Pruritus (CKD-aP). MEDICAL DECISION MAKING, Vol. 44(2) (pp NP160-NP160)
  • Pennington B & Hernandez M (2024) HOW DOES UNPAID CAREGIVING AFFECT EQ-5D? DOES THE AVERAGE TREATMENT EFFECT DIFFER FOR 3L AND 5L?. VALUE IN HEALTH, Vol. 27(12)
  • Stevely A, Holmes J, Sasso A, Alava MH, Warde A, Angus C & Meier P (2023) . SSM Annual Scientific Meeting (pp A27.2-A27)
  • Si PEH, Hernandez M, Sasso A, Gittus M, Powell R, Dunn L & Fotheringham J (2023) CKD-ASSOCIATED PRURITUS SEVERITY AND ITS ASSOCIATION WITH BODY DISTRIBUTION AND EQ-5D HEALTH-RELATED QUALITY OF LIFE IN HAEMODIALYSIS PATIENTS. NEPHROLOGY DIALYSIS TRANSPLANTATION, Vol. 38 (pp I760-I760)
  • Geue C, Hawkins N, Oakley JE, Grieve R, Hernandez M & Carpenter J (2022) A FRAMEWORK FOR EXPERT ELICITATION RELATED TO COUNTERFACTUAL VALUES: A CASE STUDY OF ELICITATION TO INFORM SUBGROUP ANALYSES IN CLINICAL TRIALS. VALUE IN HEALTH, Vol. 25(1) (pp S274-S274)
  • Si PEH, Hernandez M, Dunn L, Wilkie M & Fotheringham J (2022) SYMPTOM IMPROVEMENT WITH STANDARD CARE IN PEOPLE RECEIVING HAEMODIALYSIS ACROSS A RANGE OF SYMPTOMS IN THE POS-S RENAL: CONSIDERATION FOR CLINICAL PRACTICE AND TRIAL DESIGN. NEPHROLOGY DIALYSIS TRANSPLANTATION, Vol. 37 (pp I619-I620)
  • Geue C, Hawkins N, Oakley J, Grieve R, Hernandez M & Carpenter J (2020) A FRAMEWORK FOR EXPERT ELICITATION TO INFORM SUBGROUP ANALYSES IN CLINICAL TRIALS. MEDICAL DECISION MAKING, Vol. 40(5) (pp E410-E411)
  • Hawkins N, Geue C, Oakley J, Grieve R & Hernandez M (2020) AN EXPLORATION OF THE TRADE-OFF BETWEEN FALSE NEGATIVES AND FALSE POSITIVES WHEN IDENTIFYING SUBGROUP EFFECTS. MEDICAL DECISION MAKING, Vol. 40(1) (pp E266-E267)
  • Pennington B, Alshreef A, Flight L, Hykin P, Sivaprasad S, Brazier JE & Hernández M (2019) . Value in Health, Vol. 22(Suppl. 3) (pp S891-S891). Copenhagen, Denmark, 2 November 2019 - 2 November 2019.
  • Pennington B, Alshreef A, Flight L, Hykin P, Sivaprasad S, Brazier JE & Hernandez M (2019) MAPPING FROM VISUAL ACUITY TO UTILITY IN PATIENTS WITH MACULAR OEDEMA DUE TO CENTRAL RETINAL VEIN OCCLUSION USING DATA FROM THE LEAVO TRIAL. VALUE IN HEALTH, Vol. 22 (pp S891-S891)
  • Wailoo AJ, Stevenson M, Tosh J, Hernández M, Stevens JW, Archer R, Simpson E, everson HE, Scott D, Young A , Paisley S et al (2014) . Value in Health, Vol. 17(7) (pp a380)

Reports

  • Hernandez Alava M, Wailoo AJ, Grimm S, Pudney S, Gomes M, Sadique Z, Meads D, O'Dwyer J, Barton G & Irvine L (2017) EQ-5D-5L versus 3L: the impact on cost-effectiveness
  • Hernandez M & Pudney S (2016) Copula-based modelling of self-reported health states An application to the use of EQ-5D-3L and EQ-5D-5L in evaluating drug therapies for rheumatic disease
  • Hernandez M & Pudney SE (2016) Copula-based modelling of self-reported health states: An application to the use of EQ-5D-3L and EQ-5D-5L in evaluating drug therapies for rheumatic disease

Scholarly editions

  • Rowen D, Brazier J, Tsuchiya A, Hernández M & Ibbotson R (2009) The simultaneous valuation of states from multiple instruments using ranking and VAS data: methods and preliminary results.

Posters

  • Geue C, Hawkins N, Oakley JE, Grieve R, Hernandez M & Carpenter J (2022) POSB421 A Framework for Expert Elicitation Related to Counterfactual Values: A Case Study of Elicitation to Inform Subgroup Analyses in Clinical Trials..
  • Mukuria C, Dixon S, Rowen D & Hernandez M Examining productivity losses associated with health related quality of life using patient data (2014).

Working papers

  • Hernandez M & Pudney S () What you don't see can't hurt you? Panel data analysis and the dynamics of unobservable factors.
  • Hernandez M, Pudney S & Hancock R () The welfare cost of means-testing: pensioner participation in income support.
  • Pudney S, Hernandez M & Hancock R () The Welfare Cost of Means-Testing: Pensioner Participation in Income Support.
  • Pudney S, Hernandez M & Hancock R () The Welfare Cost of Means-Testing: Pensioner Participation in Income Support.

Datasets

  • Pennington R, Hernandez M, Hykin P, Sivaprasad S, Flight L, Alshreef A & Brazier J .

Presentations

  • Hernandez M, Wailoo A, Chrysanthou G, Carvalho P, Van der Heijde D, Santos MJ & Machado PM .

Preprints

  • Worboys HM, Gray LJ, Burton JO, Alava MH & Cooper NJ (2023) , Research Square Platform LLC.
  • Holmes J, Sasso A, Alava MH, Neves RB, Stevely AK, Warde A & Meier PS (2023) , Cold Spring Harbor Laboratory.
Teaching interests

I am interested in supervising research students in a broad range of topics in the area of microeconometric analysis.

Professional activities and memberships
  • Adjunct Associate Professor, Aalborg University, Denmark
  • Visiting research associate at the Institute for Social and Economic Research, University of Essex.